Barclays PLC Certara, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Certara, Inc. stock. As of the latest transaction made, Barclays PLC holds 70,525 shares of CERT stock, worth $754,617. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,525

Previous 70,525 -0.0%

Holding current value

$754,617

Previous $825,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$10.46 - $16.58 $490,364 - $777,270	46,880 Added 198.27%	70,525 $825,000
Q2 2024 Aug 14, 2024	SELL	$13.36 - $18.94 $226,438 - $321,014	-16,949 Reduced 41.75%	23,645 $327,000
Q1 2024 May 15, 2024	BUY	$15.65 - $19.45 $117,954 - $146,594	7,537 Added 22.8%	40,594 $726,000
Q4 2023 Feb 15, 2024	SELL	$12.12 - $18.19 $255,853 - $383,990	-21,110 Reduced 38.97%	33,057 $582,000
Q3 2023 Nov 07, 2023	BUY	$13.9 - $19.58 $184,175 - $259,434	13,250 Added 32.38%	54,167 $787,000
Q2 2023 Aug 03, 2023	BUY	$16.89 - $24.64 $65,533 - $95,603	3,880 Added 10.48%	40,917 $746,000
Q1 2023 May 04, 2023	BUY	$15.9 - $24.72 $322,372 - $501,198	20,275 Added 120.96%	37,037 $892,000
Q4 2022 Feb 13, 2023	SELL	$10.7 - $17.84 $261,422 - $435,866	-24,432 Reduced 59.31%	16,762 $269,000
Q3 2022 Nov 03, 2022	BUY	$12.84 - $24.13 $289,464 - $543,986	22,544 Added 120.88%	41,194 $547,000
Q2 2022 Aug 12, 2022	BUY	$16.75 - $22.54 $287,513 - $386,899	17,165 Added 1155.89%	18,650 $400,000
Q1 2022 May 16, 2022	BUY	$17.89 - $28.73 $26,566 - $42,664	1,485 New	1,485 $32,000

Others Institutions Holding CERT

# of Institutions

233

Shares Held

105M

Call Options Held

26.4K

Put Options Held

19.2K

View Full List

About Certara, Inc.

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $1.71B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

More about CERT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account